UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039065
Receipt number R000044554
Scientific Title An exploratory study for examining genomic profile in thymic epithelial tumors
Date of disclosure of the study information 2020/01/07
Last modified on 2020/01/07 00:46:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study for examining genomic profile in thymic epithelial tumors

Acronym

An exploratory study for examining genomic profile in thymic epithelial tumors

Scientific Title

An exploratory study for examining genomic profile in thymic epithelial tumors

Scientific Title:Acronym

An exploratory study for examining genomic profile in thymic epithelial tumors

Region

Japan


Condition

Condition

thymic epithelial tumors

Classification by specialty

Medicine in general Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To examine the genomic profile of thymic epithelial tumors

Basic objectives2

Others

Basic objectives -Others

To examine the genomic profile of thymic epithelial tumors and the potential therapeutic targets

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification of the causative gene

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Thymic epithelial tumor patients diagnosed and treated

Key exclusion criteria

1. no consent for this study before the operation
2. A case with a diagnosis other than thymic epithelial tumor after surgery

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Yamaguchi

Organization

Nagasaki University Hospital

Division name

Second Department of Internal Medicine

Zip code

852-8501

Address

1-7-1 Sakamoto, Nagasaki city, Nagasaki, Japan

TEL

095-819-7273

Email

mimatsuo-ngs@umin.ac.jp


Public contact

Name of contact person

1st name Midori
Middle name
Last name Shimada

Organization

Sasebo City General Hospital

Division name

Respiratory Medicine

Zip code

857-8511

Address

9-3 Hirase-cho, Sasebo, Nagasaki, Japan

TEL

0956-24-1515

Homepage URL


Email

mimatsuo-ngs@umin.ac.jp


Sponsor or person

Institute

Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital

Address

1-7-1 Sakamoto, Nagasaki city, Nagasaki, Japan

Tel

095-819-7273

Email

mimatsuo-ngs@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

32

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 01 Month 01 Day

Date of IRB

2013 Year 06 Month 01 Day

Anticipated trial start date

2013 Year 06 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Review the recurrence, treatment, and prognosis of cases


Management information

Registered date

2020 Year 01 Month 07 Day

Last modified on

2020 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044554


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name